The Impact
Improving the Odds.
Improving the Odds.
With up to a 50% chance of having cancer in your lifetime(1), you need to have a strategy that ensures access to the medical innovations and comprehensive support that can deliver the best outcomes. Each component of the program has been developed to address specific cancer-related challenges in the cancer journey.
Real-World Challenge
Cancer Guardian Service
40% of the most frequently shared medical links on social media are inaccurate(7)
The Cancer Information Line connects you with oncology specialists at any time to seek cancer related questions, concerns, risk-mitigation strategies, or caregiving guidance.
Up to 80% of people with a hereditary cancer risk are unaware of their increased risk(8)
Hereditary Risk Screening Test helps you to understand your genetic risk for hereditary cancers. By understanding one’s risk, preventative measures can be taken to improve your odds.
Between 4.87%-11.8% of cancers are reported to be misdiagnosed.(9)
Expert Pathology Review can be obtained quickly and easily through Cancer Guardian. A second opinion can help ensure correct diagnosis and treatment.
Chemotherapy is the “one-size-fits-all” practice, but has a median response rate of 48.6%(10)
Comprehensive Genomic Profiling, analyzing more than 300 cancer-related genes in the tumor, can help guide oncologists to prescribe personalized and more effective treatments.
Cancer diagnosis can be extremely traumatic, frightening, and leave patients feeling isolated and alone
If diagnosed, a dedicated Cancer Support Specialist is assigned to create a personalized plan to optimize health outcomes, and an On-Site Nurse Advocate can accompany you to a medical appointment to provide emotional and educational support.
Just 8% of cancer patients participate in clinical trials(3)
Clinical Trial Explorer uses up-to-the minute data to provide diagnosed members with a report listing eligible clinical trials and personalized recommendations.
Up to 73% of cancer patients suffer financial loss, and up to 42% report catastrophic financial burdens due to high out of pocket costs(4)
The Financial Navigation platform can estimate out-of-pocket financial exposure, identify appropriate financial aid programs and help members apply.
Real World Challenge
and
Cancer Guardian Service
The information below shows some of the real world challenges patients are facing.
Tab the cards to reveal the solutions Cancer Guardian’s Services can provide.
Real World Challenge:
40% of the most frequently shared medical links on social media are inaccurate(7)
Real World Challenge:
Up to 80% of people with a hereditary cancer risk are unaware of their increased risk(8)
Real World Challenge:
Between 4.87%-11.8% of cancers are reported to be misdiagnosed(9)
Real World Challenge:
Chemotherapy is the “one-size-fits-all” practice, but has a median response rate of 48.6%(10)
Real World Challenge:
Cancer diagnosis can be extremely traumatic, frightening, and leave patients feeling isolated and alone
Real World Challenge:
Just 8% of cancer patients participate in clinical trials(3)
Real World Challenge:
Up to 73% of cancer patients suffer financial loss, and up to 42% report catastrophic financial burdens due to high out of pocket costs(4)
Cancer Guardian fills in the gaps of specialized services not typically made available or covered by health insurance.
References
1. Lifetime Risk of Developing or Dying from Cancer Basic Facts. American Cancer Society, 2019.
2. Wamberg Genomic Advisors, Cancer Survey of 204 cancer patients and nonprofessional advocates. Survey Sampling International (SSI), 2018.
3. Unger, Joseph M., et al. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical and Physician and Patient Barriers to Cancer Clinical Trial Participation. JNCI J NATL Cancer Institute, 2019.
4. Family Reach. Annual Report 2016. Family Reach Foundation https://familyreachorg/wp-content/uploads/
2017/05/ frf_2016_annual_report_compressedpdf Accessed July 30, 2017.
5. CancerCare. Cancer Care Patient Access and Engagement Report. New York: CancerCare. 2016.
6. Manchanda, Ranjit, et al. Population based germline testing for primary cancer prevention. Oncotarget, 2018, Vol. 9 (No. 69), pp: 33062-33063
7. Waszak, Przemyslaw M. et al. The Spread of Medical Fake News in Social Media. Health Policy & Technology Review, Elsevier, 2018.
8. Stephen S. Raab, Dana M. Grzybicki, CA Cancer J. Clin. 2010 May-Jun,60(3): 139-65
9. Raab, Stephen S. MD, et al. Quality in Cancer Diagnosis. Cancer J. Clinical 2010
10. J. Unger, et al., Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical and Physician Barriers to Cancer Clinical Trial Participation, JNCI J Natl Cancer Inst 2019
11. The State of Cancer Care in America, 2014: A report by the American Society of Clinical Oncology. Journal of Oncology Practice, 2014; 10(2):120-122
12. Sun Life Stop-Loss Report, 2019. https://sunlife.showpad.com/share/
7SzmNmJJs1a6msorM0DZA
14. Measuring Health-Related Productivity Loss. https://ww.liebertpubl.com/doi/pdf/10.3322/caac.20068.
16. Wamberg Genomic Advisors Cancer Survey of 204 cancer patients and nonprofessional advocates fielded by Survey Sampling International (SSI), 2018. Available at: https://www.managedhealthcareexecutive.com/leukemia-and-lymphoma/
most-troubling-part-cancer-treatment-patients
